Related Experiment Video
Updated: Apr 30, 2026

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.1K
Insect sting allergy with negative venom skin test responses
D B Golden1, A Kagey-Sobotka, P S Norman
1Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA.
The Journal of Allergy and Clinical Immunology
|May 10, 2001
Summary
Negative venom skin tests do not rule out insect sting allergy. Many patients with a history of systemic reactions have negative skin tests but may still react to stings, highlighting the need for further testing.
Area of Science:
- Allergy and Immunology
- Insect Sting Reactions
- Diagnostic Testing
Background:
- A significant portion of patients with a history of systemic insect sting reactions were previously excluded from immunotherapy trials due to negative venom skin tests.
- Previous reports indicate that some patients with negative skin tests can experience severe reactions upon subsequent stings.
Purpose of the Study:
- To raise awareness regarding insect sting allergy in patients with negative skin test responses.
- To determine the frequency and clinical significance of negative venom skin test results in individuals with a documented history of systemic reactions to insect stings.
Main Methods:
- Prospective examination of negative venom skin test prevalence in patients with a history of systemic sting reactions.
- Analysis of retesting outcomes and sting challenge results in consenting patients.
Main Results:
- Out of 307 patients, 32% had negative venom skin tests. Of these, 36% had positive repeat skin tests or low positive RAST, and 7% had high IgE levels.
- Notably, 57% of patients with negative skin tests and positive histories had negative RAST results.
- Systemic reactions occurred in 21% of patients with positive skin tests and 22% of those with negative skin tests (24% with positive RAST, 14% with negative RAST).
Conclusions:
- Negative venom skin tests do not exclude the possibility of future systemic sting reactions.
- A substantial number of patients with a history of systemic sting reactions exhibit negative skin tests, sometimes accompanied by positive venom-specific IgE antibody levels.
- Repeat venom skin testing and serologic IgE antivenom testing are recommended for patients with negative initial skin tests; improved diagnostic reagents are needed.
Related Concept Videos
Allergic Reactions
26.4K
Overview
26.4K
Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivities
7.3K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.3K
Drug Toxicity: Allergic Reactions
209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
Allergic Reactions: Anaphylaxis
280
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
280
Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269

